• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 14 -6 (80) 2025 - Namozova H.J. - THE NATURE OF THE REJECTION OF BORDERLINE NEUROLOGICAL-MENTAL CHANGES IN CHRONIC BRAIN ISCHEMIA IN THE CATEGORY OF TSEREBROVASCULAR DISEASES

14 -6 (80) 2025 - Namozova H.J. - THE NATURE OF THE REJECTION OF BORDERLINE NEUROLOGICAL-MENTAL CHANGES IN CHRONIC BRAIN ISCHEMIA IN THE CATEGORY OF TSEREBROVASCULAR DISEASES

THE NATURE OF THE REJECTION OF BORDERLINE NEUROLOGICAL-MENTAL CHANGES IN CHRONIC BRAIN ISCHEMIA IN THE CATEGORY OF TSEREBROVASCULAR DISEASES

Namozova H.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Republican Specialized Scientific and Practical Center for Mental Health.

Resume

This article is devoted to the fact that psychoemotional and cognitive changes in chronic brain ischemia, which is part of the category of cranial vascular diseases, that is, tserebrovascular diseases, have their own characteristics, varying by age and gender. The main clinical manifestations of chronic brain ischemia are considered noamnestic vascular cognitive damage, in which there is relative storage of memory and acute damage to executive activity (programming and management). The fact that cognitive impairment can be classified by mild (subjective), moderate, and severe levels, and can reach severe dementia levels has been proven with the use of some examination methods. The main objective of the study was to analyze neurological, mental, psychoemotional, cognitive changes in tserebrovascular diseases and to create an optimal diagnostic method according to the results. According to the results, an examination carried out using cognitive scales shows the development of borderline mental state in chronic brain ischemia, the disappearance of self-assessment activity in patients, the most optimal scales capable of early diagnosis are proposed, which clearly demonstrate these changes. The importance of the proposed scales is interpreted as the patient diagnosis, the choice of the right treatment treatment in time, as severe cognitive complications as possible, the possibility of choosing ways to extend the period of development of disability. At the end of the study, the conclusion is made with the provision of specific recommendations on the diagnosis, prevention, treatment of chronic brain ischemia.

Keywords: chronic cerebral ischemia, symptoms of psychoemotional damage, psychoemotional tests, cognitive scales

First page

70

Last page

78

For citation:Namozova H.J. - THE NATURE OF THE REJECTION OF BORDERLINE NEUROLOGICAL-MENTAL CHANGES IN CHRONIC BRAIN ISCHEMIA IN THE CATEGORY OF TSEREBROVASCULAR DISEASES//New Day in Medicine 6(80)2025 70-78 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Чуканова Е. И., Ходмамжаров Б. Э., Чуканова А. С. Хроническая ишемия мозга (этиология, патогенез, лечение). Профилактика инсульта и сосудистая деменция // Русский медицинский журнал. – 2012;10:517-521.
  2. Шкловский В. М., Малин Д. И., Кобозев Г. Н., Селищев Г. С., Орлов И. Ю. Структура психических расстройств у больных с очаговыми органическими поражениями головного мозга сосудистого и травматического генеза и нарушениями речи, выявляемыми на этапе нейрореабилитации, и принципы их психофармакотерапии. // Социальная и клиническая психиатрия. 2012;22(2): 21-25.
  3. Aday A.W., Beckman J.A. Medical management of asymptomatic carotid artery stenosis. // Progress in cardiovascular diseases. 2017;59(6):585–590. doi: 10.1016/j.pcad.2017.05.008.
  4. Afanas'yev V. V., Rumyantseva S. A., Stupin V. A. Complex neurocytoprotection in the aspect of pharmacodynamics. Zhurnal nevrologíí ím. B. M. Man'kovs'kogo. 2017; 5 (3-4): 13-27.
  5. Antipenko E.A., Gustov A.V., Chronic brain ischemia. Current state of the problem. // Medical Council. 2016;19:38-43.
  6. Arablinskiy AV, Makotrova TA, Levin OS. Cerebral microbleeds in vascular and degenerative diseases of the brain. // Jurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(7- 2):45-51.
  7. Aizenstein HJ, Baskys A, Boldrini M, et al. Vascular depression consensus report – a critical update. BMC Med. 2016 Nov 3;14(1):161. doi: 10.1186/s12916-016-0720-5 32.
  8. Bezerra D., Sharrett A., Matsushita K. Risk factors for lacune subtypes in the atherosclerosis risk in communities (aric) study / D. Bezerra. Neurology. 2012;78:102–108.
  9. Bogolepova AN. Vascular depression and cognitive dysfunction. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(Suppl. 3):26-31. doi: 10.14412/2074- 2711-2019-3S-26-31.
  10. Brainin M. Cognitive deterioration following stroke: a growing, heavy burden for patients, families, and society. M.: Buki-Vedi, 2017. [in Russian]
  11. Brandt T, Dieterich M. Vertigo and dizziness: common complains. London: Springer; 2004. 208 p.
  12. Brown R.B., Traylor M., Burgess S., Sawcer S., Markus H.S. Do cerebral small vessel disease and multiple sclerosis share common mechanisms of white matter injury? // Stroke. 2019;50(8):1968–1972. doi: 10.1161/ STROKEAHA.118.023649.
  13. Brunyé T.T., Patterson J.E., Wooten T., Hussey E.K. A Critical Review of Cranial Electrotherapy Stimulation for Neuromodulation in Clinical and Non-clinical Samples. Front Hum Neurosci. 2021;15:625321. DOI: 10.3389/fnhum.2021.625321.
  14. Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke. 2000 Aug;31(8):2011-23. doi: 10.1161/01.str.31.8.2011 41.
  15. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;(6):7–122. (In Russ.) doi: 10.15829/1560-4071-2018-6- 7-122.
  16. Charidimou A, Linn J, Vernooij MW, et al. Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain. 2015;138(Pt 8):2126-39. doi: 10.1093/brain/awv

    file

    download